Kai Treuner

1.0k citations

41 papers · 719 indexed · h-index 14

Impact in

Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 10%
- HER2/EGFR in Cancer Research

Papers in ⓘ

Cancer Research 26
- Breast Cancer Treatment Studies 20
- Cancer Genomics and Diagnostics 4
Genetics 18
- Estrogen and related hormone effects 15

Co-authors: Rolf Knippers (4 shared papers)Carrolee Barlow (4 shared papers)Catherine A. Schnabel (25 shared papers)U. Ramsperger (1 shared paper)Dennis C. Sgroi (10 shared papers)Ranelle Salunga (10 shared papers)Elena F. Brachtel (5 shared papers)Sarah Pirrie (6 shared papers)
Journals: Journal of Clinical Oncology (11 papers)Clinical Cancer Research (6 papers)Annals of Oncology (5 papers)Cancer Research (3 papers)Journal of Thoracic Oncology (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Kai Treuner

39 papers receiving 712 citations

Peers

Countries citing papers authored by Kai Treuner

Since Specialization

Citations

This map shows the geographic impact of Kai Treuner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Treuner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Treuner more than expected).

Fields of papers citing papers by Kai Treuner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Treuner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Treuner. The network helps show where Kai Treuner may publish in the future.

Co-authors

The 25 scholars most cited alongside Kai Treuner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kai Treuner Line = papers co-authored together Kai Treuner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial Annals of Oncology ·John M.S. Bartlett, Dennis C. Sgroi, Kai Treuner, Y. Zhang, Ikhlaaq Ahmed, Tammy Piper, Ranelle Salunga, Elena F. Brachtel, Sarah Pirrie, Catherine A. Schnabel, Daniel Rea	2019	125
2	Alteration of Gene Expression by Chromosome Loss in the Postnatal Mouse Brain Journal of Neuroscience ·Dhruv Kaushal, James J. A. Contos, Kai Treuner, Amy H. Yang, Marcy A. Kingsbury, Stevens K. Rehen, Michael J. McConnell, Masaru Okabe, Carrolee Barlow, Jerold Chun	2003	79
3	Replication Protein A Induces the Unwinding of Long Double-stranded DNA Regions Journal of Molecular Biology ·Kai Treuner, U. Ramsperger, Rolf Knippers	1996	78
4	Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy Clinical Cancer Research ·Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Jenna Wong, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, Cornelis J.�H. van de Velde, Catherine A. Schnabel, Gerrit‐Jan Liefers	2020	73
5	Impaired insulin secretion in a mouse model of ataxia telangiectasia American Journal of Physiology-Endocrinology and Metabolism ·Philip D.G. Miles, Kai Treuner, Marc Latronica, Jerrold M. Olefsky, Carrolee Barlow	2007	53
6	Failed Clearance of Aneuploid Embryonic Neural Progenitor Cells Leads to Excess Aneuploidy in theAtm-Deficient But Not theTrp53-Deficient Adult Cerebral Cortex Journal of Neuroscience ·Michael J. McConnell, Dhruv Kaushal, Amy H. Yang, Marcy A. Kingsbury, Stevens K. Rehen, Kai Treuner, Robert Helton, Emily G. Annas, Jerold Chun, Carrolee Barlow	2004	50
7	Phosphorylation of Replication Protein A Middle Subunit (RPA32) Leads to a Disassembly of the RPA Heterotrimer Journal of Biological Chemistry ·Kai Treuner, Marco Findeisen, Ulrich Strausfeld, Rolf Knippers	1999	45
8	Hyperphosphorylation of replication protein A middle subunit (RPA32) in apoptosis Nucleic Acids Research ·Kai Treuner	1999	34
9	Loss of Rad52 partially rescues tumorigenesis and T-cell maturation in Atm-deficient mice Oncogene ·Kai Treuner, Rob Helton, Carrolee Barlow	2004	28
10	Chromatin Association of Replication Protein A Journal of Biological Chemistry ·Kai Treuner, Carmen Eckerich, Rolf Knippers	1998	26
11	Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study Clinical Cancer Research ·John M.S. Bartlett, Dennis C. Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Salunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Karen J. Taylor, Elena F. Brachtel, Sarah Pirrie, Catherine A. Schnabel, Daniel Rea	2022	25
12	Role of Amino-Terminal Histone Domains in Chromatin Replication Molecular and Cellular Biology ·Gianluca Quintini, Kai Treuner, Claudia Gruss, Rolf Knippers	1996	18
13	Breast Cancer Index (BCI) and prediction of benefit from extended aromatase inhibitor (AI) therapy (tx) in HR+ breast cancer: NRG oncology/NSABP B-42. Journal of Clinical Oncology ·Eleftherios P. Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C. Lucas, Charles E. Geyer, Louis Fehrenbacher, Mark L. Graham, Stephen Chia, Adam Brufsky, Janice M. Walshe, Gamini S. Soori, Shaker R. Dakhil, Soonmyung Paik, Sandra M. Swain, Dennis C. Sgroi, Catherine A. Schnabel, Norman Wolmark	2021	16
14	Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma Clinical Cancer Research ·Raquel Nunes, Tal Sella, Kai Treuner, Jennifer M. Atkinson, Jenna Wong, Yi Zhang, Pedro Exman, David J. Dabbs, Andrea L. Richardson, Catherine A. Schnabel, Dennis C. Sgroi, Steffi Oesterreich, Ashley Cimino‐Mathews, Otto Metzger	2021	13
15	Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial Clinical Cancer Research ·Eleftherios P. Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C. Lucas, Charles E. Geyer, Louis Fehrenbacher, Stephen Chia, Adam Brufsky, Janice M. Walshe, Gamini S. Soori, Shaker R. Dakhil, Soonmyung Paik, Sandra M. Swain, Dennis C. Sgroi, Catherine A. Schnabel, Norman Wolmark	2024	7
16	Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial. Journal of Clinical Oncology ·John M.S. Bartlett, Dennis C. Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Salunga, Ikhlaaq Ahmed, Kristen M. Basnet, Elena F. Brachtel, Sarah Pirrie, Catherine A. Schnabel, Daniel Rea, (unknown)	2019	7
17	Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study Breast Cancer Research ·Dennis C. Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Salunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Karen J. Taylor, Elena F. Brachtel, Sarah Pirrie, Catherine A. Schnabel, Daniel Rea, John M.S. Bartlett	2022	5
18	138MO Prognostic performance of Breast Cancer Index (BCI) in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial Annals of Oncology ·JMS Bartlett, Keying Xu, Jacqueline Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, Ranelle Salunga, E. Mallon, Karen J. Taylor, Annette Hasenburg, Christos Markopoulos, L.Y. Dirix, Caroline Seynaeve, C. van de Velde, Dan Rea, Catherine A. Schnabel, Kai Treuner, Jane Bayani	2022	5
19	Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary JCO Precision Oncology ·Harry E Fuentes, Pashtoon Murtaza Kasi, Li Ma, Lowell L. Hart, Jenna Wong, David R. Spigel, Catherine A. Schnabel, James A. Reeves, Þorvarður R. Hálfdánarson, Kai Treuner, Frank A. Greco	2024	3
20	Breast Cancer Index (BCI) and prediction of pathological complete response (pCR) to neoadjuvant chemotherapy in estrogen receptor positive (ER+) breast cancer. Journal of Clinical Oncology ·Laura M. Spring, Yi Zhang, Kai Treuner, Hannah Park, Megan Yuen, Beverly Moy, Catherine A. Schnabel, Fabrice André, Aditya Bardia	2018	3

About Kai Treuner

Kai Treuner is a scholar working on Cancer Research, Genetics, Oncology, Pulmonary and Respiratory Medicine and Developmental Neuroscience, having authored 41 papers that have together received 719 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), Estrogen and related hormone effects (15 papers), Advanced Breast Cancer Therapies (14 papers), DNA Repair Mechanisms (6 papers), Cancer Diagnosis and Treatment (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Risks and Factors (4 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Cancer Research (307 citations), Oncology (238 citations), Genetics (218 citations), Molecular Biology (397 citations) and Developmental Neuroscience (22 citations). Kai Treuner has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Rolf Knippers, Carrolee Barlow, Catherine A. Schnabel, U. Ramsperger, Dennis C. Sgroi, Ranelle Salunga, Elena F. Brachtel, Sarah Pirrie, Tammy Piper and John M.S. Bartlett. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, Cancer Research and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact